Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/21/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:YOTAWYotta Acquisition Corporation
05/21/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTCYBiotricity Inc
05/21/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLCEChildrens Place Inc
05/21/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPISPI Energy Company Ltd
05/21/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FKWLFranklin Wireless Corporation
05/21/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AIZNAssurant Inc
05/21/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AIZNAssurant Inc
05/21/20245:00PMBusiness WireFranklin Resources, Inc. Announces Quarterly DividendNYSE:BENFranklin Resources Inc
05/21/20245:00PMGlobeNewswire Inc.NFI announces John Proven as President of NFI Parts and ARBOCTSX:NFI.DBNFI Group Inc
05/21/20245:00PMGlobeNewswire Inc.NFI announces John Proven as President of NFI Parts and ARBOCNFI-DB
05/21/20245:00PMGlobeNewswire Inc.NFI announces John Proven as President of NFI Parts and ARBOCTSX:NFINFI Group Inc
05/21/20245:00PMGlobeNewswire Inc.200 East 84th Street Owner’s Corp. Selects Maxwell-Kates, Inc. As Managing Agent
05/21/20245:00PMGlobeNewswire Inc.Helium Evolution Announces Filing of Q1-2024 Financial ResultsTSXV:HEVIHelium Evolution Incorporated
05/21/20245:00PMGlobeNewswire Inc.BioCardia Announces Reverse Stock SplitNASDAQ:BCDABioCardia Inc
05/21/20245:00PMPR Newswire (US)Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic EsophagitisTSX:EPRXEupraxia Pharmaceuticals Inc
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:BASEEvolve Global Materials & Mining Enhanced Yield Index ETF
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:ESPXEvolve S&P 500 Enhanced Yield Fund
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:LEADEvolve Future Leadership Fund
05/21/20245:00PMPR Newswire (US)UpGuard Announces Automated Scanning Enhancements And Executive Appointments to Further Support Security Teams With Cybersecurity Challenges
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:LIFEEvolve Global Healthcare Enhanced Yield Fund
05/21/20245:00PMPR Newswire (Canada)Banxa Reports Record Profitable March Quarter and Updates GuidanceTSXV:BNXABanxa Holdings Inc
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:EBNKEvolve European Banks Enhanced Yield ETF
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:TECHEvolve Fangma Index ETF
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:DATAEvolve Cloud Computing Index Fund
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:BANKEvolve CA Banks and Lifecos Enhanced Yield Index Fd ETF
05/21/20245:00PMPR Newswire (US)Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic EsophagitisNASDAQ:EPRXEupraxia Pharmaceuticals Inc
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:EARNEvolve Active Global Fixed Income Fund
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:CYBREvolve Cyber Security Index Fund
05/21/20245:00PMPR Newswire (Canada)Evolve Announces May 2024 Distributions for Certain Evolve FundsTSX:QQQYEvolve NASDAQ Technology Enhanced Yield Index Fund
05/21/20245:00PMPR Newswire (Canada)Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic EsophagitisNASDAQ:EPRXEupraxia Pharmaceuticals Inc

Your Recent History

Delayed Upgrade Clock